Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio Gets CE-IVD Mark for SARS-CoV-2 Test

NEW YORK — Takara Bio Europe said on Tuesday that it has received CE-IVD marking for an RT-qPCR-based test for the detection of SARS-CoV-2.

The Takara SARS-CoV-2 Direct PCR detection kit is designed to detect regions of the SARS-CoV-2 nucleocapsid genes in nasopharyngeal or nasal swab samples, as well as crude saliva samples. It does not require RNA extraction and provides results within 60 minutes, the company said.

The test was approved in Japan last year, Takara Bio Europe said.

Takara Bio Europe is a French subsidiary of Japan's Takara Bio.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.